Skip to product search
DISCOUNT ON

Abvida 50 Mg Tablet (15 Tab)

Vildagliptin (50mg)

15 TABLETProduct code 242860

YOUR PURCHASE PRICE

Out of stock
—

Inclusive of all taxes

Choose your batch

0 offers

No batches are available at this hub. Choose another hub to check availability.

Delivery from your selected hubDelivery details will be confirmed

Sign in to order for your pharmacy.

Product information

Manufacturer
Abbott Healthcare Pvt. Ltd.
Category
Allopathy
Composition
Vildagliptin (50mg)
Packaging
15 TABLET
Box / case pack
1 / —
Description

ABVIDA 50 MG TABLET

ABVIDA 50 MG TABLET is a medication manufactured by Abbott Healthcare Pvt. Ltd..

  • Name: ABVIDA 50 MG TABLET.
  • Composition: Each tablet contains Vildagliptin 50 mg. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor.
  • Uses: ABVIDA 50 MG TABLET is primarily used for the treatment of type 2 diabetes mellitus. It is prescribed for adults when diet and exercise alone, or in combination with other diabetes medications, are not sufficient to control blood sugar levels. It helps prevent serious complications of diabetes such as kidney damage, eyesight loss, nerve problems, and cardiovascular issues.
  • Dosage and Administration: The typical recommended dose for most adult patients with type 2 diabetes is 50mg twice daily, often taken with meals. It can also be prescribed once daily, preferably in the morning. The tablet can be taken with or without food, but for optimal benefits, it should be taken at the same time each day. Do not chew or crush the tablet; swallow it whole with water. The dosage may vary based on individual factors and should be followed as directed by a healthcare professional.
  • Side Effects: Common side effects include hypoglycemia (low blood sugar), tremors, headaches, dizziness, fatigue, and nausea. Other possible side effects may include upper respiratory tract infection, muscle pain, constipation, and swelling in the hands, ankles, or feet. Serious side effects like lactic acidosis, pancreatitis, liver disease, or severe allergic reactions (e.g., angioedema) require immediate medical attention.
  • Precautions: ABVIDA 50 MG TABLET is not recommended for type 1 diabetes or diabetic ketoacidosis. Inform your doctor if you have a history of kidney disease, heart disease, liver disease, or pancreatic problems. Pregnant or breastfeeding women should consult their doctor before use. Alcohol consumption should be limited as it can increase the risk of low blood sugar levels. Regular monitoring of kidney function and blood glucose levels may be necessary. Caution is advised when driving or operating machinery if dizziness occurs. Do not stop the medication abruptly without consulting your doctor.
  • Storage: Store ABVIDA 50 MG TABLET below 25°C or 30°C, protected from moisture, direct sunlight, and heat. Keep it out of the reach of children.
Frequently asked questions

ABVIDA 50 MG TABLET (15 TAB) from Abbott Healthcare Pvt. Ltd. contains the active ingredient Vildagliptin 50 mg. Vildagliptin is an oral antidiabetic medication used to manage type 2 diabetes mellitus.

Here are some frequently asked questions about ABVIDA 50 MG TABLET:

What is ABVIDA 50 MG TABLET used for?

ABVIDA 50 MG TABLET is primarily used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels, especially when diet and exercise alone are insufficient, or when other medications are not effectively controlling blood sugar. It can be used alone or in combination with other antidiabetic medications like metformin, sulfonylureas, or insulin. By improving glycemic control, it aims to reduce the risk of diabetes-related complications such as kidney damage, eyesight loss, and nerve problems.

How does ABVIDA 50 MG TABLET work?

ABVIDA 50 MG TABLET contains Vildagliptin, which is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by preventing the breakdown of natural hormones called incretins, specifically Glucagon-Like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP). By inhibiting DPP-4, Vildagliptin increases the levels of these incretin hormones, which then stimulate the pancreas to produce more insulin and reduce the production of glucagon, both in a glucose-dependent manner. This dual action helps lower blood glucose levels, particularly after meals, and improves overall glycemic control.

What is the usual dosage of ABVIDA 50 MG TABLET?

The dosage of ABVIDA 50 MG TABLET is determined by your doctor based on your individual condition and response to treatment. The maximum recommended daily dose is typically 100 mg.

  • As monotherapy or in combination with metformin or a glitazone: The usual dose is 100 mg daily, administered as 50 mg in the morning and 50 mg in the evening.
  • In combination with a sulfonylurea: The recommended dose is 50 mg once daily, taken in the morning.
  • For patients with moderate to severe kidney disease or on dialysis: The recommended dose is 50 mg once daily. The tablets can be taken with or without food.

What are the possible side effects of ABVIDA 50 MG TABLET?

Like all medications, ABVIDA 50 MG TABLET can cause side effects, although not everyone experiences them. Common side effects include headache, dizziness, nausea, and trembling. Other reported side effects may include muscle pain, joint pain, constipation, diarrhea, heartburn, vomiting, excessive sweating, and a runny nose or sore throat. Hypoglycemia (low blood sugar) can occur, especially when Vildagliptin is used in combination with other diabetes medications like sulfonylureas or insulin. Rare but serious side effects can include inflammation of the pancreas (pancreatitis) and liver problems (hepatitis). Swelling of the face, tongue, or throat (angioedema) has also been reported. If you experience any persistent or severe side effects, or symptoms like yellow skin/eyes or severe stomach pain, consult your doctor immediately.

Is ABVIDA 50 MG TABLET safe during pregnancy or breastfeeding?

ABVIDA 50 MG TABLET (Vildagliptin) is generally not recommended during pregnancy. There is insufficient data on its use in pregnant women, and animal studies have shown reproductive toxicity at high doses, making the potential risk to humans unknown. If you are pregnant, planning to conceive, or think you may be pregnant, consult your doctor for advice, as insulin therapy is often preferred for managing diabetes during pregnancy. It is unknown if Vildagliptin is excreted in human milk, so it should not be used while breastfeeding.

Can ABVIDA 50 MG TABLET be taken with other medications?

ABVIDA 50 MG TABLET can interact with other medications, and it's important to inform your doctor about all medicines, supplements, or herbal remedies you are currently taking.

  • Other antidiabetic medications (e.g., insulin, sulfonylureas, metformin): Taking Vildagliptin with these can increase the risk of low blood sugar (hypoglycemia). Your doctor may adjust the dosage of these medications.
  • Certain other active substances: Thiazides, corticosteroids, thyroid medicines, and sympathomimetics may reduce the blood glucose-lowering effect of Vildagliptin.
  • ACE inhibitors: There may be an increased risk of angioedema (swelling) when Vildagliptin is taken with ACE inhibitors.
  • Anti-fungal medications (e.g., ketoconazole) or certain antibiotics (e.g., rifampicin): These may affect the concentration or effectiveness of Vildagliptin.

What precautions should be taken with ABVIDA 50 MG TABLET?

Several precautions should be considered before and during treatment with ABVIDA 50 MG TABLET:

  • Liver and Kidney Problems: Use with caution if you have liver problems, or moderate to severe kidney impairment. Liver function tests should be performed before starting treatment and monitored regularly during the first year, then periodically. Vildagliptin is generally not recommended for patients with hepatic impairment.
  • Pancreatitis: Rare reports of acute pancreatitis have been associated with Vildagliptin. Use with caution if you have a history of pancreatitis, and discontinue if pancreatitis is suspected.
  • Heart Failure: Use with caution in patients with heart failure.
  • Type 1 Diabetes or Diabetic Ketoacidosis: Vildagliptin is not for use in patients with type 1 diabetes or diabetic ketoacidosis.
  • Allergies: Do not take if you are allergic to Vildagliptin or any of its components.
  • Skin: Monitor for skin disorders like blistering or ulceration.
  • Alcohol: Avoid excessive alcohol intake as it can affect blood sugar levels and may increase the risk of side effects.
  • Children and Adolescents: Not recommended for use in children and adolescents under 18 years of age.

What happens if a dose is missed?

If you miss a dose of ABVIDA 50 MG TABLET, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten tablet.

How should ABVIDA 50 MG TABLET be stored?

ABVIDA 50 MG TABLET should be stored at room temperature, generally not exceeding 30°C. Keep it in its original packaging, away from moisture, heat, and direct sunlight. Ensure it is kept out of the reach and sight of children and pets. Do not use the medicine after its expiry date.